OLANZAPINE

Product NDC
70518-3054
11-digit product format
705183054
Labeler code
70518
Product ID
70518-3054_be4d8f01-aade-85dd-e053-2995a90af802
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Olanzapine
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA202050
Marketing category
ANDA
Marketing start
2021-03-23
Marketing end
0000-00-00
Substance
OLANZAPINE
Active strength
10 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3054-02023-03-15C16284748780-1f386c64a-1307-0266-e053-dadaa90a7c1a6a14cd3e-2753-4d4d-aef7-c9874d81e8dc
70518-3054-02023-01-30C16284748780-1f386c64a-1307-0266-e053-dadaa90a7c1a6a14cd3e-2753-4d4d-aef7-c9874d81e8dc

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3054-07051830540030 TABLET in 1 BLISTER PACK (70518-3054-0) 30 tablet2021-03-230000-00-00NoNoCurrent